84 related articles for article (PubMed ID: 10199372)
1. Coronary risk assessment methods and cholesterol lowering.
Smith GD; Ebrahim S
Lancet; 1999 Mar; 353(9158):1097. PubMed ID: 10199372
[No Abstract] [Full Text] [Related]
2. Lowering of LDL cholesterol.
Sniderman AD
Lancet; 2000 Jan; 355(9199):235. PubMed ID: 10675147
[No Abstract] [Full Text] [Related]
3. Cost effectiveness of coronary prevention.
Szucs TD; März W
Eur Heart J; 1999 Feb; 20(4):317-8. PubMed ID: 10099929
[No Abstract] [Full Text] [Related]
4. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Mason JM; Freemantle N
JAMA; 1999 Feb; 281(5):415-6; author reply 417-9. PubMed ID: 9952194
[No Abstract] [Full Text] [Related]
5. Coronary risk assessment methods and cholesterol lowering.
Stokoe JM; Jones DW; Beevers DG
Lancet; 1999 Mar; 353(9158):1097-8. PubMed ID: 10199374
[No Abstract] [Full Text] [Related]
6. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Siegel D; Swislocki AL
JAMA; 1999 Feb; 281(5):417-9. PubMed ID: 9952198
[No Abstract] [Full Text] [Related]
7. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
McDiarmid TD; Hensel WA
JAMA; 1999 Feb; 281(5):416; author reply 417-9. PubMed ID: 9952195
[No Abstract] [Full Text] [Related]
8. Lowering of LDL cholesterol.
Payne N; McCabe C
Lancet; 1999 Oct; 354(9185):1207-8. PubMed ID: 10513735
[No Abstract] [Full Text] [Related]
9. Economic benefits of aggressive lipid lowering: a managed care perspective.
McKenney JM; Kinosian B
Am J Manag Care; 1998 Jan; 4(1):65-74. PubMed ID: 10179907
[TBL] [Abstract][Full Text] [Related]
10. Economics of drug treatment: for which patients is it costeffective to lower cholesterol?
Jönsson B
Lancet; 2001 Oct; 358(9289):1251-6. PubMed ID: 11675082
[TBL] [Abstract][Full Text] [Related]
11. Cost implications of lipid-lowering treatments.
Reckless JP
Pharmacoeconomics; 1994 Oct; 6(4):310-23. PubMed ID: 10147467
[TBL] [Abstract][Full Text] [Related]
12. [Victory in primary prevention--or? Can we afford to translate results from the West-of-Scotland Study into general practice?].
Klose G
Fortschr Med; 1996 Jun; 114(17):231-2. PubMed ID: 8767302
[No Abstract] [Full Text] [Related]
13. Cost and health implications of cholesterol lowering.
Goldman L; Gordon DJ; Rifkind BM; Hulley SB; Detsky AS; Goodman DW; Kinosian B; Weinstein MC
Circulation; 1992 May; 85(5):1960-8. PubMed ID: 1572059
[TBL] [Abstract][Full Text] [Related]
14. Should cholesterol-lowering drugs be used routinely to treat moderate hypercholesterolemia in patients with serum cholesterol levels of 6.20 to 6.85 mmol/L (240 to 265 mg/dL). An opposing view.
Zweig S
J Fam Pract; 1988 Jun; 26(6):670-5. PubMed ID: 3132527
[No Abstract] [Full Text] [Related]
15. Use of cholesterol-lowering drugs United States, 1992.
Stat Bull Metrop Insur Co; 1993; 74(4):10-7. PubMed ID: 8266279
[TBL] [Abstract][Full Text] [Related]
16. [Broader indication for treatment with statins; the 'heart protection study'].
Stalenhoef AF; Stuyt PM
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1921-3. PubMed ID: 12404905
[TBL] [Abstract][Full Text] [Related]
17. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
Hernborg A; Hjemdahl P; Håkansson J
Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
[No Abstract] [Full Text] [Related]
18. More on pravastatin and coronary disease.
Grundy SM
N Engl J Med; 1996 Oct; 335(16):1239-40. PubMed ID: 8999328
[No Abstract] [Full Text] [Related]
19. Cholesterol and coronary heart disease: screening and treatment.
Ebrahim S; Smith GD; McCabe C; Payne N; Pickin M; Sheldon TA; Lampe F; Sampson F; Ward S; Wannamthee G
Qual Health Care; 1998 Dec; 7(4):232-9. PubMed ID: 10339027
[No Abstract] [Full Text] [Related]
20. Should smoking be an indication for lipid-lowering therapy?
Peeters A; Demos LL; McNeil JJ
Med J Aust; 1999 Mar; 170(5):240. PubMed ID: 10092930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
